Chewable eye health formulation
US10918664B2 · kind B2 · utility
0Cited by
1References
6Claims
0Family size
Inventors
Key dates
| Filing date | Mar 30, 2018 |
| Grant date | Feb 16, 2021 |
| Priority date | — |
| Expiry date | Mar 30, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K36/45
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Risk of visual impairment including Age-Related Macular Degeneration (AMD) and cataracts increase with age. This increased risk can be caused by changes in the structure and function of the eye or changes in structures of the central nervous system that support visual perception. The present invention comprises fruit flavored, chewable formulations of supplements for reducing the risk of AMD. Chewable dosage forms of the invention are preferred over other formulations and may increase compliance in an aging population, who are more likely to require an eye health supplement and have an increased risk of experiencing dysphagia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.